Skip to main content

Laboratory Assessment of Skeletal Status

  • Chapter
Atlas of Osteoporosis

Abstract

Bone turnover markers have been used in medicine for over 70 years. They have proved indispensable in the management of metabolic bone diseases such as Paget’s disease of bone. The changes in bone turnover in osteoporosis are small; thus, markers that are not specific to bone were not very useful in investigating this disease. However, assays have recently been introduced that are more specific for bone. In this chapter, we consider the evidence for the use of these markers in the investigation of osteoporosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Delmas PD, Eastell R, Garnero P, et al.: The use of biochemical markers of bone turnover in osteoporosis. Osteoporosis Int 2000, 11 (suppl 6): S2–S 17.

    Article  CAS  Google Scholar 

  2. Rogers A, Hannon R, Eastell R: Biochemical markers as predictors of rates of bone loss after menopause. J Bone Miner Res 2000, 15:1398–1404.

    Article  PubMed  CAS  Google Scholar 

  3. Garnero P, Dargent-Molina P, Hans D, et al.: Do markers of bone resorption add to bone mineral density and ultrasonographic heel measurement for the prediction of hip fracture in elderly women? The EPIDOS prospective study. Osteoporosis Int 1998, 8:563–569.

    Article  CAS  Google Scholar 

  4. Kanis JA, Johnell O, Oden A, et al.: Ten-year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporosis Int 2001, 12:989–995.

    Article  CAS  Google Scholar 

  5. Braga de Castro MA, Hannon R, Eastell R: Monitoring alendronate therapy for osteoporosis. J Bone Miner Res 1999, 14:602–608.

    Article  Google Scholar 

  6. Tannenbaum C, Clark J, Schwartzman K, et al.: Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocrinol Metab 2002, 87: 4431–4437.

    Article  PubMed  CAS  Google Scholar 

  7. Eastell R, Barton I, Hannon R, et al.: Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate. J Bone Miner Res, in press.

    Google Scholar 

  8. Eastell R, Bainbridge PR: Bone turnover markers: their place in the investigation of osteoporosis. In Osteoporosis: Pathophysiology and Clinical Management Edited by Orwoll ES, Bliziotes M. Totowa, NJ: Humana Press; 2003:185–198.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer Science+Business Media New York

About this chapter

Cite this chapter

Eastell, R., Bainbridge, P.R. (2003). Laboratory Assessment of Skeletal Status. In: Orwoll, E.S. (eds) Atlas of Osteoporosis. Current Medicine Group, London. https://doi.org/10.1007/978-1-4757-4561-0_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-4561-0_7

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4757-4563-4

  • Online ISBN: 978-1-4757-4561-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics